Published in:
Open Access
01-12-2024 | Breast Cancer | Matters Arising
Comment on “A novel
super-enhancer-related gene signature predicts prognosis and immune microenvironment for
breast cancer”
Authors:
Matin Chehelgerdi, Milad Khorramian-Ghahfarokhi, Fereshteh Behdarvand Dehkordi, Mohammad Chehelgerdi
Published in:
BMC Cancer
|
Issue 1/2024
Login to get access
Abstract
The primary aim of this study is to critically evaluate and comment on
the research presented in the article titled “A Novel Super-Enhancer-Related
Gene Signature Predicts Prognosis and Immune Microenvironment for Breast
Cancer” by Wu et al. Our specific objectives include assessing the
methodology employed by the authors, particularly in regard to the utilization of a
super-enhancer-related gene signature for breast cancer prognosis prediction. We
propose the necessity of subgroup analysis to effectively address the heterogeneity
in breast cancer subtypes, which is crucial for the applicability of the SERGs
across diverse breast cancer cases. Additionally, we suggest conducting a more
comprehensive immune panel study to deepen the understanding of how the immune
microenvironment impacts breast cancer prognosis. Our commentary seeks to provide
valuable insights into the strengths and weaknesses of the study, contributing to a
more comprehensive understanding of its findings and potential clinical
implications.